# OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
> **ANDA209199** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2025-07-25
## Drug
- **FDA Application Number:** ANDA209199
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- **Generic name:** OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD V
- **Manufacturer:** Camber Pharmaceuticals, Inc.
- **First approval:** 2025-07-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209199)
---
*AI Analytics · CC0 1.0*